{"id":132527,"date":"2026-05-12T11:17:18","date_gmt":"2026-05-12T11:17:18","guid":{"rendered":"https:\/\/indogenmed.org\/resource\/generic-tagrisso-osimertinib-lung-cancer\/"},"modified":"2026-09-20T02:35:49","modified_gmt":"2026-09-20T02:35:49","slug":"generic-tagrisso-osimertinib-lung-cancer","status":"publish","type":"post","link":"https:\/\/indogenmed.org\/zh-hans\/resource\/generic-tagrisso-osimertinib-lung-cancer\/","title":{"rendered":"\u4eff\u5236\u6cf0\u745e\u6c99\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u5982\u4f55\u6cbb\u7597\u80ba\u764c"},"content":{"rendered":"<div class=\"medical-review-disclosure\" style=\"background: #f9f9f9; padding: 15px; border-left: 5px solid #1E419B; margin-bottom: 25px; border-radius: 4px; font-size: 0.95em; line-height: 1.5;\"><strong>\u533b\u5b66\u5ba1\u6838\uff1a<\/strong>\u672c\u6587\u5df2\u4e8e2026\u5e745\u670812\u65e5\u7531\u6211\u4eec\u7684<strong>\u4e34\u5e8a\u652f\u6301\u56e2\u961f<\/strong>\u5ba1\u6838\u3002<\/div>\n<p><a href=\"https:\/\/indogenmed.org\/medicine\/lung-cancer\/\" target=\"_blank\" rel=\"noopener\">\u80ba\u764c<\/a>\u4ecd\u662f\u5168\u7403\u764c\u75c7\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u4e4b\u4e00\u3002\u5e78\u8fd0\u7684\u662f\uff0c\u968f\u7740\u65b0\u7597\u6cd5\u7684\u51fa\u73b0\uff0c\u643a\u5e26\u7279\u5b9a\u57fa\u56e0\u6539\u53d8\u7684\u60a3\u8005\u73b0\u5728\u53ef\u4ee5\u83b7\u5f97\u5408\u9002\u7684\u6cbb\u7597\u3002<\/p>\n<p>\u5176\u4e2d\u6700\u91cd\u8981\u7684\u8fdb\u5c55\u4e4b\u4e00\u662f<a href=\"https:\/\/indogenmed.org\/product\/tagrisso-80mg-tablets\/\" target=\"_blank\" rel=\"noopener\">\u6cf0\u745e\u6c99\uff08Tagrisso\uff09<\/a>\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u7684\u95ee\u4e16\uff0c\u5b83\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u67d0\u4e9bEGFR\u7a81\u53d8\u6240\u81f4\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7684\u9776\u5411\u836f\u7269\u3002<\/p>\n<p>\u5982\u4eca\uff0c\u7531\u4e8e\u4ef7\u683c\u66f4\u5b9e\u60e0\uff0c\u4eff\u5236\u6cf0\u745e\u6c99\u8d8a\u6765\u8d8a\u53d7\u5230\u5173\u6ce8\u3002<\/p>\n<p>\u672c\u6587\u5c06\u4ecb\u7ecd\u4ec0\u4e48\u662f\u6cf0\u745e\u6c99\u6cbb\u7597\u3001\u4e3a\u4ec0\u4e48<a href=\"https:\/\/indogenmed.org\/zh-hans\/molecule\/osimertinib\/\" target=\"_blank\" rel=\"noopener\">\u5965\u5e0c\u66ff\u5c3c<\/a>\u6cbb\u7597\u80ba\u764c\u662f\u4e00\u79cd\u9769\u547d\u6027\u7684\u65b9\u6cd5\uff0c\u4ee5\u53ca\u6cf0\u745e\u6c9980\u6beb\u514b\u5728\u5206\u5b50\u6c34\u5e73\u4e0a\u5982\u4f55\u8d77\u4f5c\u7528\u3002<\/p>\n<h2>\u4ec0\u4e48\u662f\u6cf0\u745e\u6c99\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\uff1f<\/h2>\n<p>\u6cf0\u745e\u6c99\u662f<a href=\"https:\/\/indogenmed.org\/zh-hans\/resource\/osimertinib-first-line-therapy-approvals-for-lung-cancer\/\" target=\"_blank\" rel=\"noopener\">\u5965\u5e0c\u66ff\u5c3c<\/a>\u7684\u54c1\u724c\u540d\uff0c\u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cd\u7b2c\u4e09\u4ee3EGFR\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u5b9a\u7c7b\u578b\u7684\u80ba\u764c\u3002<\/p>\n<p>\u4e3b\u8981\u7528\u4e8e\uff1a<\/p>\n<ul>\n<li>EGFR\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09<\/li>\n<li>\u665a\u671f\u6216\u8f6c\u79fb\u6027\u80ba\u764c<\/li>\n<li>\u643a\u5e26T790M\u7b49\u7279\u5b9a\u8010\u836f\u7a81\u53d8\u7684\u80ba\u764c<\/li>\n<\/ul>\n<p>\u6cf0\u745e\u6c99\u5c5e\u4e8e\u9776\u5411\u6cbb\u7597\uff0c\u5373\u4e13\u95e8\u653b\u51fb\u5e26\u6709EGFR\u7a81\u53d8\u7684\u764c\u7ec6\u80de\uff0c\u4e0e\u4f20\u7edf\u5316\u7597\u76f8\u6bd4\uff0c\u5bf9\u5065\u5eb7\u7ec6\u80de\u7684\u635f\u4f24\u66f4\u5c0f\u3002<\/p>\n<h2>\u4e86\u89e3\u80ba\u764c\u4e2d\u7684EGFR<\/h2>\n<p>\u8981\u4e86\u89e3\u6cf0\u745e\u6c99\u9776\u5411\u6cbb\u7597\u7684\u539f\u7406\uff0c\u9996\u5148\u9700\u8981\u4e86\u89e3EGFR\u3002<\/p>\n<h3>\u4ec0\u4e48\u662fEGFR\uff1f<\/h3>\n<p>EGFR\u5373\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff0c\u662f\u5b58\u5728\u4e8e\u8bb8\u591a\u7ec6\u80de\u8868\u9762\u7684\u4e00\u79cd\u86cb\u767d\u8d28\uff0c\u53c2\u4e0e\uff1a<\/p>\n<ul>\n<li>\u7ec6\u80de\u751f\u957f<\/li>\n<li>\u7ec6\u80de\u5206\u88c2<\/li>\n<li>\u751f\u5b58\u4fe1\u53f7\u4f20\u9012<\/li>\n<\/ul>\n<p>\u6b63\u5e38\u60c5\u51b5\u4e0b\uff0cEGFR\u5e2e\u52a9\u5065\u5eb7\u7ec6\u80de\u751f\u957f\u548c\u4fee\u590d\u3002<\/p>\n<h2>EGFR\u7a81\u53d8\u578b\u80ba\u764c\u4e2d\u53d1\u751f\u4e86\u4ec0\u4e48\uff1f<\/h2>\n<p>\u5728\u67d0\u4e9b\u7c7b\u578b\u7684\u80ba\u764c\u4e2d\uff0cEGFR\u57fa\u56e0\u4f1a\u53d1\u751f\u7a81\u53d8\uff0c\u4f7f\u8fd9\u79cd\u86cb\u767d\u6301\u7eed\u5904\u4e8e\u6fc0\u6d3b\u72b6\u6001\u3002<\/p>\n<p>\u56e0\u6b64\uff1a<\/p>\n<ul>\n<li>\u7ec6\u80de\u4e0d\u53d7\u63a7\u5236\u5730\u589e\u6b96<\/li>\n<li>\u80bf\u7624\u751f\u957f\u66f4\u5feb<\/li>\n<li>\u7ec6\u80de\u9003\u907f\u51cb\u4ea1\uff08\u7a0b\u5e8f\u6027\u7ec6\u80de\u6b7b\u4ea1\uff09<\/li>\n<\/ul>\n<p>\u8fd9\u79cd\u7a81\u53d8\u5e38\u89c1\u4e8e\uff1a<\/p>\n<ul>\n<li>\u4e0d\u5438\u70df\u8005<\/li>\n<li>\u4e9a\u88d4\u4eba\u7fa4<\/li>\n<li>\u817a\u764c\u578b\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005<\/li>\n<\/ul>\n<h2>\u6cf0\u745e\u6c99\u53ef\u6cbb\u7597\u54ea\u4e9b\u7c7b\u578b\u7684\u80ba\u764c\uff1f<br \/>\n<\/h2>\n<p>\u643a\u5e26EGFR\u7a81\u53d8\u7684\u80ba\u764c\u53ef\u80fd\u9002\u5408\u4f7f\u7528\u6cf0\u745e\u6c99\u6cbb\u7597\u3002\u6839\u636e\u5177\u4f53\u60c5\u51b5\uff0c\u53ef\u4ee5\u5355\u72ec\u670d\u7528\uff0c\u5728\u624b\u672f\u5207\u9664\u80bf\u7624\u4e4b\u524d\u6216\u4e4b\u540e\u4f7f\u7528\uff0c\u6216\u4e0e\u5176\u4ed6\u6297\u80ba\u764c\u836f\u7269\u8054\u5408\u4f7f\u7528\u3002<\/p>\n<h2>\u5982\u4f55\u4f7f\u7528\u6cf0\u745e\u6c99\u6cbb\u7597\u80ba\u764c\uff1f<br \/>\n<\/h2>\n<p>\u6cf0\u745e\u6c99\u4e3a\u53e3\u670d\u836f\u7269\uff0c\u6bcf\u5929\u670d\u7528\u4e00\u7247\uff0c\u7a7a\u8179\u6216\u968f\u9910\u5747\u53ef\u3002<\/p>\n<p>\u8bf7\u5c3d\u91cf\u6bcf\u5929\u5728\u540c\u4e00\u65f6\u95f4\u670d\u7528\u3002\u6839\u636e\u6b64\u524d\u63a5\u53d7\u7684\u6cbb\u7597\uff0c\u53ef\u80fd\u9700\u8981\u670d\u7528\u957f\u8fbe\u4e09\u5e74\uff08\u672f\u540e\u8f85\u52a9\u6cbb\u7597\uff09\uff0c\u6216\u53ea\u8981\u6709\u6548\u4e14\u8010\u53d7\u826f\u597d\u5c31\u6301\u7eed\u670d\u7528\u3002<\/p>\n<p>\u5982\u51fa\u73b0\u67d0\u4e9b\u526f\u4f5c\u7528\uff0c\u533b\u751f\u53ef\u80fd\u4f1a\u51cf\u5c11\u5242\u91cf\u3001\u6682\u505c\u670d\u836f\u6216\u5b8c\u5168\u505c\u7528\u6cf0\u745e\u6c99\u3002<\/p>\n<h2>\u6cf0\u745e\u6c99\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u5982\u4f55\u8d77\u4f5c\u7528<\/h2>\n<h3>\u6cf0\u745e\u6c99\u7684\u4f5c\u7528\u673a\u5236<\/h3>\n<p>\u6cf0\u745e\u6c99\u4e13\u95e8\u9776\u5411\u5e76\u963b\u65ad\u7a81\u53d8\u7684EGFR\u86cb\u767d\u3002<\/p>\n<p>\u5f53\u5965\u5e0c\u66ff\u5c3c\u4e0e\u5f02\u5e38\u7684EGFR\u53d7\u4f53\u7ed3\u5408\u65f6\uff1a<\/p>\n<ul>\n<li>\u5173\u95ed\u764c\u75c7\u751f\u957f\u4fe1\u53f7<\/li>\n<li>\u963b\u6b62\u764c\u7ec6\u80de\u589e\u6b96<\/li>\n<li>\u4fc3\u8fdb\u764c\u7ec6\u80de\u6b7b\u4ea1\uff08\u51cb\u4ea1\uff09<\/li>\n<\/ul>\n<p>\u4ece\u800c\u51cf\u7f13\u80bf\u7624\u751f\u957f\uff0c\u751a\u81f3\u53ef\u80fd\u4f7f\u80bf\u7624\u7f29\u5c0f\u3002<\/p>\n<h3>\u7b80\u5355\u6765\u8bf4\uff1a<\/h3>\n<ul>\n<li>EGFR\u7a81\u53d8\uff1d\u764c\u75c7\u751f\u957f\u7684\u201c\u5f00\u542f\u5f00\u5173\u201d<\/li>\n<li>\u6cf0\u745e\u6c99\uff1d\u628a\u5f00\u5173\u5173\u6389<\/li>\n<\/ul>\n<h2>\u6cf0\u745e\u6c99\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u6cbb\u7597\u80ba\u764c\u7684\u6548\u679c\u5982\u4f55\uff1f<br \/>\n<\/h2>\n<p>\u6cf0\u745e\u6c99\u83b7\u5f97FDA\u6279\u51c6\u662f\u57fa\u4e8e\u591a\u9879\u9488\u5bf9\u4e0d\u540c\u60c5\u51b5\u7684EGFR\u7a81\u53d8\u80ba\u764c\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u7814\u7a76\u5bf9\u8c61\u4e3aEGFR\u7a81\u53d8\u80ba\u764c\u60a3\u8005\uff0c\u4ed6\u4eec\u66fe\u63a5\u53d7\u624b\u672f\u5207\u9664\u80bf\u7624\uff0c\u90e8\u5206\u4eba\u8fd8\u63a5\u53d7\u8fc7\u5316\u7597\u3002<\/p>\n<p>\u5728\u540d\u4e3aADAURA\u7684\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u6cf0\u745e\u6c99\u4e0e\u5b89\u6170\u5242\u8fdb\u884c\u4e86\u6bd4\u8f83\u3002<\/p>\n<p>\u5b89\u6170\u5242\u662f\u4e00\u79cd\u4e0d\u542b\u6709\u6548\u6210\u5206\u7684\u7269\u8d28\uff0c\u5728\u8bd5\u9a8c\u4e2d\u4f5c\u4e3a\u5bf9\u7167\u4f7f\u7528\u3002\u7ed3\u679c\u663e\u793a\uff0c\u6cf0\u745e\u6c99\u5728\u8fd9\u4e00\u4eba\u7fa4\u4e2d\u7684\u7597\u6548\u4f18\u4e8e\u5b89\u6170\u5242\u3002<\/p>\n<p>\u8be5\u7814\u7a76\u5171\u7eb3\u5165682\u4eba\uff0c\u6d4b\u91cf\u4ece\u5f00\u59cb\u7528\u836f\u5230\u764c\u75c7\u590d\u53d1\u6216\u6b7b\u4ea1\u7684\u65f6\u95f4\u3002<\/p>\n<p>\u8fd9\u4e00\u6307\u6807\u79f0\u4e3a\u65e0\u75c5\u751f\u5b58\u671f\uff08DFS\uff09\u3002\u6cf0\u745e\u6c99\u7ec4\u7684\u4e2d\u4f4dDFS\u5c1a\u672a\u8fbe\u5230\uff08\u8d85\u8fc7\u4e00\u534a\u7684\u60a3\u8005\u4ecd\u672a\u590d\u53d1\uff09\uff0c\u800c\u5b89\u6170\u5242\u7ec4\u4e3a27.5\u4e2a\u6708\u3002<\/p>\n<section>\n<p dir=\"ltr\">\u8be5\u8bd5\u9a8c\u8fd8\u8003\u5bdf\u4e86\u603b\u751f\u5b58\u671f\uff08OS\uff09\uff0c\u5373\u5f00\u59cb\u670d\u7528\u6cf0\u745e\u6c99\u6216\u5b89\u6170\u5242\u540e\u7684\u5b58\u6d3b\u65f6\u95f4\uff0c\u4ee55\u5e74\u751f\u5b58\u7387\u8868\u793a\uff0c\u5373\u5f00\u59cb\u6cbb\u75975\u5e74\u540e\u4ecd\u5b58\u6d3b\u7684\u6bd4\u4f8b\uff1a\u6cf0\u745e\u6c99\u7ec4\u4e3a88%\uff0c\u5b89\u6170\u5242\u7ec4\u4e3a78%\u3002<\/p>\n<p dir=\"ltr\">\u4e5f\u5c31\u662f\u8bf4\uff0c\u5f00\u59cb\u6cbb\u75975\u5e74\u540e\uff0c\u670d\u7528\u6cf0\u745e\u6c99\u7684\u60a3\u8005\u4e2d\u670988%\u4ecd\u7136\u5b58\u6d3b\u3002<\/p>\n<p dir=\"ltr\">\u6cf0\u745e\u6c99\u8fd8\u5728\u672a\u63a5\u53d7\u8fc7\u8f6c\u79fb\u671f\u5316\u7597\u7684EGFR\u7a81\u53d8\u8f6c\u79fb\u6027\u80ba\u764c\u60a3\u8005\u4e2d\u8fdb\u884c\u4e86\u7814\u7a76\u3002\u5728FLAURA\u8bd5\u9a8c\u4e2d\uff0c\u5b83\u4e0e\u5176\u4ed6EGFR\u6fc0\u9176\u6291\u5236\u5242\uff08\u5384\u6d1b\u66ff\u5c3c\u6216\u5409\u975e\u66ff\u5c3c\uff09\u8fdb\u884c\u6bd4\u8f83\uff0c\u7597\u6548\u66f4\u597d\u3002<\/p>\n<p dir=\"ltr\">\u8be5\u8bd5\u9a8c\u7eb3\u5165556\u4eba\uff0c\u89c2\u5bdf\u80ba\u764c\u8fdb\u5c55\uff08\u5373\u751f\u957f\u6216\u6269\u6563\uff09\u6240\u9700\u7684\u65f6\u95f4\uff0c\u79f0\u4e3a\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u3002\u6cf0\u745e\u6c99\u7ec4\u7684\u4e2d\u4f4dPFS\u4e3a18.9\u4e2a\u6708\uff0c\u5bf9\u7167\u7ec4\u4e3a10.2\u4e2a\u6708\u3002<\/p>\n<p dir=\"ltr\">\u8fd9\u610f\u5473\u7740\u670d\u7528\u6cf0\u745e\u6c99\u7684\u60a3\u8005\u4e2d\u6709\u4e00\u534a\u81f3\u5c1118.9\u4e2a\u6708\u5185\u764c\u75c7\u6ca1\u6709\u8fdb\u5c55\u3002<\/p>\n<p dir=\"ltr\">\u7814\u7a76\u8fd8\u8bc4\u4f30\u4e86\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\uff0c\u5373\u63a5\u53d7\u67d0\u79cd\u836f\u7269\u7684\u60a3\u8005\u4e2d\u6709\u4e00\u534a\u4ecd\u5b58\u6d3b\u7684\u65f6\u95f4\u3002\u6cf0\u745e\u6c99\u7ec4\u4e3a38.6\u4e2a\u6708\uff0c\u5bf9\u7167\u7ec4\u4e3a31.8\u4e2a\u6708\u3002<\/p>\n<p dir=\"ltr\">\u6b64\u5916\uff0c\u6cf0\u745e\u6c99\u8fd8\u5728\u65e2\u5f80\u672a\u63a5\u53d7\u8fc7\u665a\u671f\u5316\u7597\u7684EGFR\u7a81\u53d8\u665a\u671f\u80ba\u764c\u60a3\u8005\u4e2d\uff0c\u4e0e\u57f9\u7f8e\u66f2\u585e\u53ca\u542b\u94c2\u5316\u7597\u8054\u5408\u4f7f\u7528\u8fdb\u884c\u4e86\u8bc4\u4f30\u3002<\/p>\n<p dir=\"ltr\">\u5728FLAURA2\u7814\u7a76\u4e2d\uff0c\u8be5\u8054\u5408\u65b9\u6848\u4e0e\u6cf0\u745e\u6c99\u5355\u836f\u8fdb\u884c\u4e86\u6bd4\u8f83\uff0c\u7ed3\u679c\u663e\u793a\u8054\u5408\u65b9\u6848\u5728EGFR\u7a81\u53d8\u665a\u671f\u80ba\u764c\u4e2d\u7684\u7597\u6548\u66f4\u597d\u3002<\/p>\n<p dir=\"ltr\">\u8be5\u7814\u7a76\u5171\u7eb3\u5165557\u540d\u60a3\u8005\u3002\u8054\u5408\u6cbb\u7597\u7684\u4e2d\u4f4dPFS\u4e3a25.5\u4e2a\u6708\uff0c\u6cf0\u745e\u6c99\u5355\u836f\u4e3a16.7\u4e2a\u6708\u3002<\/p>\n<p dir=\"ltr\">\u56e0\u6b64\uff0c\u63a5\u53d7\u8054\u5408\u6cbb\u7597\u7684\u60a3\u8005\u4e2d\u6709\u4e00\u534a\u5728\u8d85\u8fc725.5\u4e2a\u6708\u5185\u75be\u75c5\u6ca1\u6709\u8fdb\u5c55\u3002<\/p>\n<p dir=\"ltr\">\u6cf0\u745e\u6c99\u4e5f\u5728\u65e2\u5f80\u81f3\u5c11\u63a5\u53d7\u8fc7\u4e00\u7ebf\u6cbb\u7597\uff08\u5305\u62ec\u6297EGFR\u6cbb\u7597\uff09\u7684EGFR\u7a81\u53d8\u80ba\u764c\u60a3\u8005\u4e2d\u8fdb\u884c\u4e86\u8bc4\u4f30\u3002\u5165\u7ec4\u60a3\u8005\u90fd\u5fc5\u987b\u643a\u5e26EGFR T790M\u7a81\u53d8\u5e76\u60a3\u6709\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3002<\/p>\n<p dir=\"ltr\">\u5728AURA3\u7814\u7a76\u4e2d\uff0c\u6cf0\u745e\u6c99\u4e0e\u5316\u7597\u8fdb\u884c\u4e86\u6bd4\u8f83\uff0c\u5728\u65e2\u5f80\u6cbb\u7597\u8fc7\u7684\u60a3\u8005\u4e2d\u7597\u6548\u4f18\u4e8e\u5316\u7597\u3002\u8be5\u8bd5\u9a8c\u5171\u7eb3\u5165419\u540d\u60a3\u8005\u3002<\/p>\n<p dir=\"ltr\">\u6cf0\u745e\u6c99\u7ec4\u7684\u4e2d\u4f4dPFS\u4e3a10.1\u4e2a\u6708\uff0c\u5316\u7597\u7ec4\u4e3a4.4\u4e2a\u6708\uff0c\u5373\u670d\u7528\u6cf0\u745e\u6c99\u7684\u60a3\u8005\u4e2d\u6709\u4e00\u534a\u81f3\u5c1110.1\u4e2a\u6708\u5185\u75be\u75c5\u6ca1\u6709\u8fdb\u5c55\u3002<\/p>\n<p dir=\"ltr\">\u6cf0\u745e\u6c99\u7ec4\u7684\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\u4e3a26.8\u4e2a\u6708\uff0c\u5316\u7597\u7ec4\u4e3a22.5\u4e2a\u6708\uff08\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5316\u7597\u7ec4\u8bb8\u591a\u60a3\u8005\u968f\u540e\u4e5f\u63a5\u53d7\u4e86\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\uff09\u3002<\/p>\n<\/section>\n<h2>\u6cf0\u745e\u6c99\u4e0e\u65e9\u671fEGFR\u7597\u6cd5\u6709\u4f55\u4e0d\u540c<\/h2>\n<p>\u65e9\u671f\u7684EGFR\u6291\u5236\u5242\uff0c\u5982\uff1a<\/p>\n<ul>\n<li><a href=\"https:\/\/indogenmed.org\/zh-hans\/molecule\/erlotinib\/\" target=\"_blank\" rel=\"noopener\">\u5384\u6d1b\u66ff\u5c3c<\/a><\/li>\n<li><a href=\"https:\/\/indogenmed.org\/zh-hans\/molecule\/gefitinib\/\" target=\"_blank\" rel=\"noopener\">\u5409\u975e\u66ff\u5c3c<\/a><\/li>\n<\/ul>\n<p>\u6700\u521d\u6709\u6548\uff0c\u4f46\u8bb8\u591a\u60a3\u8005\u540e\u6765\u51fa\u73b0\u4e86\u8010\u836f\u3002<\/p>\n<p>\u5176\u4e2d\u4e00\u79cd\u4e3b\u8981\u7684\u8010\u836f\u7a81\u53d8\u662f\uff1a<\/p>\n<h3>EGFR T790M\u7a81\u53d8<\/h3>\n<p>\u6cf0\u745e\u6c99\u4e13\u95e8\u8bbe\u8ba1\u7528\u4e8e\uff1a<\/p>\n<ul>\n<li>\u9776\u5411\u5e38\u89c1\u7684EGFR\u7a81\u53d8<\/li>\n<li>\u514b\u670dT790M\u8010\u836f\u7a81\u53d8<\/li>\n<li>\u66f4\u597d\u5730\u8fdb\u5165\u5927\u8111\u548c\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf<\/li>\n<\/ul>\n<p>\u8fd9\u4f7f\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u80ba\u764c\u6210\u4e3a\u9776\u5411\u6cbb\u7597\u7684\u4e00\u5927\u8fdb\u6b65\u3002<\/p>\n<h2>\u6cf0\u745e\u6c99\u53ef\u6cbb\u7597\u7684\u5e38\u89c1EGFR\u7a81\u53d8<\/h2>\n<h3>EGFR\u5916\u663e\u5b5019\u7f3a\u5931<\/h3>\n<p>\u6700\u5e38\u89c1\u7684EGFR\u7a81\u53d8\u4e4b\u4e00\u3002<\/p>\n<h3>EGFR L858R\u7a81\u53d8<\/h3>\n<p>\u53e6\u4e00\u79cd\u5e38\u89c1\u7684\u6fc0\u6d3b\u7a81\u53d8\u3002<\/p>\n<h3>EGFR T790M\u7a81\u53d8<\/h3>\n<p>\u4e0e\u65e9\u671f\u7597\u6cd5\u7684\u8010\u836f\u6709\u5173\u3002<\/p>\n<h2>\u4eff\u5236\u6cf0\u745e\u6c99\uff1a\u60a3\u8005\u987b\u77e5<\/h2>\n<h3>\u4ec0\u4e48\u662f\u4eff\u5236\u6cf0\u745e\u6c99\uff1f<\/h3>\n<p>\u4eff\u5236\u6cf0\u745e\u6c99\u542b\u6709\u76f8\u540c\u7684\u6709\u6548\u6210\u5206\uff1a<\/p>\n<h3>\u5965\u5e0c\u66ff\u5c3c<\/h3>\n<p>\u5176\u8bbe\u8ba1\u76ee\u7684\u662f\u63d0\u4f9b\u76f8\u540c\u7684\uff1a<\/p>\n<ul>\n<li>\u4f5c\u7528\u673a\u5236<\/li>\n<li>\u7597\u6548<\/li>\n<li>\u5b89\u5168\u6027<\/li>\n<\/ul>\n<p>\u540c\u65f6\u53ef\u80fd\u66f4\u5b9e\u60e0\u3001\u66f4\u6613\u83b7\u5f97\u3002<\/p>\n<h3>\u4eff\u5236\u6cf0\u745e\u6c99\u4e0e\u54c1\u724c\u6cf0\u745e\u6c99<\/h3>\n<p>\u4e24\u8005\u90fd\u5177\u6709\uff1a<\/p>\n<ul>\n<li>\u6709\u6548\u6210\u5206\u4e3a\u5965\u5e0c\u66ff\u5c3c<\/li>\n<li>\u76f8\u4f3c\u7684\u5242\u91cf\u89c4\u683c<\/li>\n<li>\u76f8\u4f3c\u7684\u6cbb\u7597\u4f5c\u7528<\/li>\n<\/ul>\n<p>\u6700\u5e38\u7528\u7684\u5242\u91cf\u4e3a80\u6beb\u514b\uff0c\u6bcf\u65e5\u4e00\u6b21\u3002<\/p>\n<h2>\u6cf0\u745e\u6c99\u6cbb\u7597\u7684\u4e34\u5e8a\u76ca\u5904<\/h2>\n<h3>1. \u6539\u5584\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09<\/h3>\n<p>\u4e34\u5e8a\u7814\u7a76\u663e\u793a\uff0c\u4e0e\u65e9\u671fEGFR\u6291\u5236\u5242\u76f8\u6bd4\uff0c\u6cf0\u745e\u6c99\u663e\u8457\u5ef6\u7f13\u4e86\u764c\u75c7\u8fdb\u5c55\u3002<\/p>\n<h3>FLAURA\u8bd5\u9a8c\u7ed3\u679c\uff1a<\/h3>\n<ul>\n<li>\u4e2d\u4f4d\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff1a\n<ul>\n<li>\u6cf0\u745e\u6c99\uff1a18.9\u4e2a\u6708<\/li>\n<li>\u65e9\u671fEGFR\u7597\u6cd5\uff1a10.2\u4e2a\u6708<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\u8fd9\u610f\u5473\u7740\u670d\u7528\u6cf0\u745e\u6c99\u7684\u60a3\u8005\u5728\u764c\u75c7\u6076\u5316\u524d\u5b58\u6d3b\u7684\u65f6\u95f4\u66f4\u957f\u3002<\/p>\n<h3>2. \u66f4\u597d\u7684\u603b\u751f\u5b58\u671f<\/h3>\n<p>\u670d\u7528\u6cf0\u745e\u6c99\u7684\u60a3\u8005\u603b\u751f\u5b58\u671f\u4e5f\u6709\u6240\u6539\u5584\u3002<\/p>\n<h3>\u4e34\u5e8a\u7ed3\u679c\uff1a<\/h3>\n<ul>\n<li>\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\uff1a\n<ul>\n<li>\u6cf0\u745e\u6c99\uff1a38.6\u4e2a\u6708<\/li>\n<li>\u5bf9\u7167\u7597\u6cd5\uff1a31.8\u4e2a\u6708<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3>3. \u6709\u6548\u63a7\u5236\u8111\u8f6c\u79fb<\/h3>\n<p>\u5965\u5e0c\u66ff\u5c3c\u7684\u4e00\u5927\u4f18\u52bf\u662f\u80fd\u591f\u7a7f\u8fc7\u8840\u8111\u5c4f\u969c\u3002<\/p>\n<p>\u8fd9\u4f7f\u5b83\u80fd\u591f\uff1a<\/p>\n<ul>\n<li>\u6cbb\u7597\u8111\u8f6c\u79fb<\/li>\n<li>\u964d\u4f4e\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u8fdb\u5c55\u7684\u98ce\u9669<\/li>\n<\/ul>\n<p>\u8fd9\u4e00\u70b9\u5c24\u4e3a\u91cd\u8981\uff0c\u56e0\u4e3aEGFR\u7a81\u53d8\u80ba\u764c\u5e38\u5e38\u8f6c\u79fb\u5230\u5927\u8111\u3002<\/p>\n<h2>\u6cf0\u745e\u6c99\u4f5c\u4e3a\u672f\u540e\u8f85\u52a9\u6cbb\u7597<\/h2>\n<h3>ADAURA\u8bd5\u9a8c<\/h3>\n<p>\u6cf0\u745e\u6c99\u4e5f\u7528\u4e8e\u65e9\u671f\u80ba\u764c\u672f\u540e\uff0c\u4ee5\u964d\u4f4e\u590d\u53d1\u98ce\u9669\u3002<\/p>\n<h4>\u4e3b\u8981\u7ed3\u679c\uff1a<\/h4>\n<ul>\n<li>5\u5e74\u751f\u5b58\u7387\uff1a\n<ul>\n<li>\u6cf0\u745e\u6c99\uff1a88%<\/li>\n<li>\u5b89\u6170\u5242\uff1a78%<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\u8fd9\u4e00\u7ed3\u679c\u786e\u7acb\u4e86\u6cf0\u745e\u6c99\u4f5c\u4e3a\u91cd\u8981\u7684\u8f85\u52a9\u9776\u5411\u6cbb\u7597\u7684\u5730\u4f4d\u3002<\/p>\n<h2>\u6cf0\u745e\u6c99\u7684\u5e38\u89c1\u526f\u4f5c\u7528<\/h2>\n<p><a href=\"https:\/\/indogenmed.org\/zh-hans\/resource\/osimertinib-side-effects-common-long-term-risks\/\" target=\"_blank\" rel=\"noopener\">\u5965\u5e0c\u66ff\u5c3c\u7684\u526f\u4f5c\u7528<\/a>.<\/p>\n<h3>\u5e38\u89c1\u526f\u4f5c\u7528\uff1a<\/h3>\n<ul>\n<li>\u8179\u6cfb<\/li>\n<li>\u76ae\u75b9\u6216\u76ae\u80a4\u5e72\u71e5<\/li>\n<li>\u6307\u7532\u53d8\u5316<\/li>\n<li>\u75b2\u52b3<\/li>\n<li>\u53e3\u8154\u6e83\u75a1<\/li>\n<\/ul>\n<h3>\u4e25\u91cd\u526f\u4f5c\u7528<\/h3>\n<p>\u7f55\u89c1\u4f46\u4e25\u91cd\u7684\u5e76\u53d1\u75c7\u5305\u62ec\uff1a<\/p>\n<ul>\n<li>\u80ba\u90e8\u708e\u75c7\uff08\u95f4\u8d28\u6027\u80ba\u75c5\uff09<\/li>\n<li>\u5fc3\u5f8b\u95ee\u9898<\/li>\n<li>\u773c\u90e8\u75be\u75c5<\/li>\n<li>\u9aa8\u9ad3\u6291\u5236<\/li>\n<\/ul>\n<p>\u60a3\u8005\u5982\u51fa\u73b0\u4ee5\u4e0b\u60c5\u51b5\uff1a<\/p>\n<ul>\n<li>\u54b3\u55fd<\/li>\n<li>\u547c\u5438\u6025\u4fc3<\/li>\n<li>\u80f8\u75db<\/li>\n<li>\u89c6\u529b\u53d8\u5316<\/li>\n<\/ul>\n<p>\u5e94\u7acb\u5373\u544a\u77e5\u533b\u7597\u4eba\u5458\u3002<\/p>\n<h2>\u5982\u4f55\u76d1\u6d4b\u6cbb\u7597\u6548\u679c\uff1f<\/h2>\n<p>\u6cf0\u745e\u6c99\u4ece\u7b2c\u4e00\u6b21\u670d\u836f\u8d77\u5c31\u5f00\u59cb\u53d1\u6325\u4f5c\u7528\u3002\u533b\u751f\u901a\u5e38\u4f1a\u5728\u5f00\u59cb\u6cbb\u7597\u7ea6\u516d\u5468\u540e\u8fdb\u884c\u5f71\u50cf\u68c0\u67e5\uff0c\u8bc4\u4f30\u836f\u7269\u5bf9\u80bf\u7624\u7684\u6548\u679c\u3002<\/p>\n<p>\u533b\u751f\u4e5f\u53ef\u80fd\u51b3\u5b9a\u5728\u516d\u5468\u4e4b\u524d\u6216\u4e4b\u540e\u8fdb\u884c\u68c0\u67e5\uff0c<\/p>\n<p>\u8fd9\u53d6\u51b3\u4e8e\u54ea\u79cd\u5b89\u6392\u6700\u9002\u5408\u60a8\u3002<\/p>\n<p>\u533b\u751f\u901a\u5e38\u8fd8\u4f1a\u5b9a\u671f\u8fdb\u884c\u8840\u6db2\u68c0\u67e5\u7b49\u68c0\u6d4b\uff0c\u4e86\u89e3\u836f\u7269\u5728\u4f53\u5185\u7684\u4f5c\u7528\uff0c\u5305\u62ec\u76d1\u6d4b\u767d\u7ec6\u80de\u3001\u4e2d\u6027\u7c92\u7ec6\u80de\u548c\u8840\u5c0f\u677f\u6c34\u5e73\uff0c\u4ee5\u786e\u8ba4\u60a8\u53ef\u4ee5\u5b89\u5168\u5730\u7ee7\u7eed\u670d\u7528\u6cf0\u745e\u6c99\u3002<\/p>\n<p>\u5982\u51fa\u73b0\u54b3\u55fd\u3001\u547c\u5438\u6025\u4fc3\u7b49\u526f\u4f5c\u7528\uff0c\u53ef\u80fd\u9700\u8981\u8fdb\u884c\u66f4\u591a\u68c0\u67e5\uff0c\u4ee5\u786e\u8ba4\u7ee7\u7eed\u7528\u836f\u662f\u5426\u5b89\u5168\u3002<\/p>\n<h2>\u5982\u4f55\u9884\u9632\u548c\u5904\u7406\u526f\u4f5c\u7528\uff1f<\/h2>\n<p>\u764c\u75c7\u6cbb\u7597\u836f\u7269\u4f1a\u5f15\u8d77\u591a\u79cd\u4e0d\u826f\u53cd\u5e94\uff0c\u6cf0\u745e\u6c99\u4e5f\u4e0d\u4f8b\u5916\u3002<\/p>\n<p>\u670d\u7528\u6cf0\u745e\u6c99\u671f\u95f4\uff0c\u8bf7\u62a5\u544a\u4efb\u4f55\u526f\u4f5c\u7528\uff0c\u4ee5\u4fbf\u8bc4\u4f30\u5176\u4e25\u91cd\u7a0b\u5ea6\uff0c\u5e76\u83b7\u5f97\u5e94\u5bf9\u5efa\u8bae\u3002<\/p>\n<p>\u533b\u751f\u53ef\u80fd\u4f1a\u6839\u636e\u60a8\u7684\u526f\u4f5c\u7528\u5f00\u5177\u5176\u4ed6\u836f\u7269\u3002<\/p>\n<p>\u4f8b\u5982\uff0c\u670d\u7528\u6cf0\u745e\u6c99\u671f\u95f4\u51fa\u73b0\u8179\u6cfb\u65f6\uff0c\u533b\u751f\u4f1a\u5efa\u8bae\u591a\u559d\u6c34\u3001\u8865\u5145\u542b\u7535\u89e3\u8d28\u7684\u996e\u6599\uff0c\u5e76\u670d\u7528\u6b62\u6cfb\u836f\u3002<\/p>\n<p>\u5982\u679c\u60a8\u5728\u670d\u7528\u6cf0\u745e\u6c99\u7684\u540c\u65f6\u63a5\u53d7\u57f9\u7f8e\u66f2\u585e\u548c\u542b\u94c2\u5316\u7597\uff0c\u533b\u751f\u53ef\u80fd\u4f1a\u5efa\u8bae\u60a8\u5728\u8f93\u6db2\u524d\u670d\u7528\u4e00\u4e9b\u836f\u7269\uff0c\u4ee5\u9884\u9632\u6700\u5e38\u89c1\u7684\u526f\u4f5c\u7528\u2014\u2014\u6076\u5fc3\u548c\u5455\u5410\u3002<\/p>\n<p>\u8fd9\u4e9b\u526f\u4f5c\u7528\u901a\u5e38\u7531\u5316\u7597\u8f93\u6db2\u5f15\u8d77\u3002\u8bf7\u52a1\u5fc5\u9075\u5faa\u8fd9\u4e9b\u5efa\u8bae\uff0c\u4e5f\u53ef\u4ee5\u5411\u533b\u751f\u8be2\u95ee\u8fd8\u6709\u54ea\u4e9b\u65b9\u6cd5\u53ef\u4ee5\u9884\u9632\u548c\u5904\u7406\u5e38\u89c1\u526f\u4f5c\u7528\u3002<\/p>\n<p>\u5403\u6e05\u6de1\u7684\u98df\u7269\uff0c\u6bcf\u5929\u5c11\u91cf\u591a\u9910\uff0c\u800c\u4e0d\u662f\u4e00\u65e5\u4e09\u987f\u5927\u9910\uff0c\u6709\u52a9\u4e8e\u9884\u9632\u548c\u7f13\u89e3\u6076\u5fc3\u3001\u5455\u5410\u548c\u8179\u6cfb\u3002<\/p>\n<p>\u6839\u636e\u526f\u4f5c\u7528\u7684\u7c7b\u578b\uff0c\u53ef\u80fd\u9700\u8981\u51cf\u5c11\u5242\u91cf\u3001\u6682\u505c\u8f93\u6db2\uff0c\u751a\u81f3\u505c\u7528\u6cf0\u745e\u6c99\u3002<\/p>\n<p>\u8fd9\u4e9b\u8c03\u6574\u53d6\u51b3\u4e8e\u526f\u4f5c\u7528\u7684\u7c7b\u578b\u548c\u4e25\u91cd\u7a0b\u5ea6\u3002\u533b\u751f\u51b3\u5b9a\u51cf\u91cf\u7684\u76ee\u7684\u662f\u5728\u964d\u4f4e\u6bd2\u6027\u7684\u540c\u65f6\u5c3d\u91cf\u4fdd\u6301\u6cbb\u7597\u6548\u679c\u3002<\/p>\n<h2>\u8fd8\u6709\u54ea\u4e9b\u91cd\u8981\u6ce8\u610f\u4e8b\u9879\uff1f<\/h2>\n<p>\u6cf0\u745e\u6c99\u53ef\u80fd\u5bf9\u80ce\u513f\u9020\u6210\u4f24\u5bb3\u3002\u533b\u751f\u4f1a\u544a\u8bc9\u60a8\u670d\u836f\u671f\u95f4\u7684\u907f\u5b55\u65b9\u6cd5\u3002<\/p>\n<p>\u5982\u679c\u60a8\u6709\u53ef\u80fd\u6000\u5b55\uff0c\u5728\u6700\u540e\u4e00\u6b21\u670d\u7528\u6cf0\u745e\u6c99\u540e\u76846\u5468\u5185\u5e94\u91c7\u53d6\u6709\u6548\u907f\u5b55\u63aa\u65bd\u3002<\/p>\n<p>\u5982\u679c\u60a8\u662f\u7537\u6027\uff0c\u4e14\u5973\u6027\u4f34\u4fa3\u6709\u53ef\u80fd\u6000\u5b55\uff0c\u5728\u6700\u540e\u4e00\u6b21\u670d\u7528\u6cf0\u745e\u6c99\u540e\u76844\u4e2a\u6708\u5185\u5e94\u91c7\u53d6\u6709\u6548\u907f\u5b55\u63aa\u65bd\u3002<\/p>\n<p>\u6cf0\u745e\u6c99\u53ef\u80fd\u5f15\u8d77\u4e25\u91cd\u7684\u4e0d\u826f\u53cd\u5e94\uff0c\u5f71\u54cd\u80ba\u3001\u5fc3\u810f\u3001\u773c\u775b\u3001\u76ae\u80a4\u4ee5\u53ca\u8840\u6db2\u548c\u9aa8\u9ad3\u3002<\/p>\n<p>\u52a1\u5fc5\u5c06\u4e0d\u826f\u53cd\u5e94\u544a\u77e5\u533b\u7597\u4eba\u5458\uff0c\u5c24\u5176\u662f\u51fa\u73b0\u54b3\u55fd\u3001\u547c\u5438\u56f0\u96be\u3001\u5fc3\u8df3\u52a0\u5feb\u3001\u89c6\u529b\u6a21\u7cca\u3001\u53d1\u70ed\u6216\u76ae\u80a4\u8131\u76ae\u8d77\u75b1\u7b49\u60c5\u51b5\u65f6\u3002<\/p>\n<h2>\u7ed3\u8bba<\/h2>\n<p>\u6cf0\u745e\u6c99\uff08\u5965\u5e0c\u66ff\u5c3c\uff09\u901a\u8fc7\u4e13\u95e8\u9488\u5bf9\u764c\u75c7\u751f\u957f\u7684\u5206\u5b50\u9a71\u52a8\u56e0\u7d20\uff0c\u5f7b\u5e95\u6539\u53d8\u4e86EGFR\u7a81\u53d8\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7684\u6cbb\u7597\u3002\u5b83\u80fd\u591f\u514b\u670d\u8010\u836f\u7a81\u53d8\u3001\u63a7\u5236\u8111\u8f6c\u79fb\u5e76\u6539\u5584\u751f\u5b58\uff0c\u662f\u73b0\u4ee3\u80ba\u764c\u6cbb\u7597\u4e2d\u6700\u91cd\u8981\u7684\u8fdb\u5c55\u4e4b\u4e00\u3002<\/p>\n<p>\u4eff\u5236\u6cf0\u745e\u6c99\u7684\u51fa\u73b0\u4e5f\u53ef\u80fd\u6539\u5584\u5168\u7403\u8bb8\u591a\u60a3\u8005\u83b7\u5f97\u6cbb\u7597\u7684\u673a\u4f1a\u3002\u65e0\u8bba\u662f\u7528\u4e8e\u65e9\u671f\u8f85\u52a9\u6cbb\u7597\u8fd8\u662f\u8f6c\u79fb\u6027\u75be\u75c5\uff0c\u6cf0\u745e\u6c9980\u6beb\u514b\u90fd\u5728\u7cbe\u51c6\u80bf\u7624\u5b66\u4e2d\u53d1\u6325\u7740\u6838\u5fc3\u4f5c\u7528\u3002<\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<ol>\n<li>WebMD\u2014\u2014\u6cf0\u745e\u6c99\u5982\u4f55\u6cbb\u7597\u80ba\u764c\uff1f<br \/><a href=\"https:\/\/www.webmd.com\/lung-cancer\/tagrisso-non-small-cell-lung-cancer\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/www.webmd.com\/lung-cancer\/tagrisso-non-small-cell-lung-cancer<\/a><\/li>\n<\/ol>\n<h2>\u533b\u5b66\u514d\u8d23\u58f0\u660e<\/h2>\n<p>\u672c\u5185\u5bb9\u4ec5\u4f9b\u53c2\u8003\uff0c\u4e0d\u80fd\u66ff\u4ee3\u4e13\u4e1a\u7684\u533b\u7597\u5efa\u8bae\u3001\u8bca\u65ad\u6216\u6cbb\u7597\u3002\u5f00\u59cb\u6216\u66f4\u6539\u4efb\u4f55\u764c\u75c7\u6cbb\u7597\u524d\uff0c\u8bf7\u52a1\u5fc5\u54a8\u8be2\u5408\u683c\u7684\u533b\u7597\u4e13\u4e1a\u4eba\u5458\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u533b\u5b66\u5ba1\u6838\uff1a\u672c\u6587\u5df2\u4e8e2026\u5e745\u670812\u65e5\u7531\u6211\u4eec\u7684\u4e34\u5e8a\u652f\u6301\u56e2\u961f\u5ba1\u6838\u3002 \u80ba\u764c\u4ecd\u662f\u5168\u7403\u764c\u75c7\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u4e4b\u4e00\u3002\u5e78\u8fd0\u7684\u662f [&hellip;]<\/p>\n","protected":false},"author":124,"featured_media":132533,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6122,5954],"tags":[],"class_list":["post-132527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer-medicine","category-generic-drugs"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/posts\/132527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/users\/124"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=132527"}],"version-history":[{"count":0,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/posts\/132527\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/media\/132533"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=132527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=132527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=132527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}